Skip to content

Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment

Oral Neoplasm

The purpose of this observational study is to evaluate the utility of the S100A7 immunohistochemistry signature-based assessment - STRATICYTE - in determining the risk of progression to cancer of clinically suspicious oral lesions.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    15 to 90

Participation Criteria

Inclusion Criteria:

* Any clinically suspicious lesion biopsied to rule-out oral epithelial dysplasia/oral squamous cell carcinoma

Exclusion Criteria:

* Biopsied lesion with or without dysplasia concomitant with oral squamous cell carcinoma at initial biopsy

Study Location

University of Alberta
University of Alberta
Edmonton, Alberta
Canada

Contact Study Team

Primary Contact

Tim McGaw, DDS, MSc, MD

Kingsway Oral & Maxillofacial Surgery
Kingsway Oral & Maxillofacial Surgery
Edmonton, Alberta
Canada

Contact Study Team

Primary Contact

Tim McGaw, DDS, MSc, MD

Western University
Western University
London, Ontario
Canada

Contact Study Team

Primary Contact

Mark Darling, MSc, MChD

Study Sponsored By
Proteocyte Diagnostics Inc.
Participants Required
More Information
Study ID: NCT04622462